Industry Trends

Industry Trends

Analyze emerging developments in technology and healthcare, highlighting their impact on markets and investment opportunities

The Biotech Reset: Narrative, Translatability and AI

February 9, 2026

Hospitals Build In-House ChatGPTs for Medical Records

January 28, 2026

FDA Halts Gene Therapy Trials After Tumor Case

January 28, 2026

Roche Advances Obesity Drug After Strong Phase 2

January 27, 2026

OpenEvidence Raises $250M, Valued at $12B

January 21, 2026

FDA Clears First Multi-Condition Radiology AI Tool

January 21, 2026

GSK Buys RAPT to Bolster Immunology Pipeline

January 20, 2026

Consumer Health AI Spreads, Trust and Validation Lag

January 12, 2026

FDA Deregulates Digital Health, Opening Door for AI

January 7, 2026

Stopping GLP-1s Reverses Weight, Heart Benefits

January 7, 2026

AI Antibody Design Advances, But Revolution Still Distant

January 6, 2026

Who Pays for Healthcare AI Is Still Unsettled

January 2, 2026

Novo Undercuts Lilly With Wegovy Pill Pricing

December 30, 2025

Brain-Computer Implants Enter Commercial Inflection Phase

December 26, 2025

FDA Clears Wegovy Pill, Expanding GLP-1 Access

December 23, 2025

Biotech IPO Window Likely Reopens in 2026

December 22, 2025

Child Death Shakes Brain-Targeted Gene Therapy

December 15, 2025

FDA Approves First Novel Gonorrhea Drug Decades

December 14, 2025

Hospitals Adopt Generative AI Faster Than Expected

December 13, 2025

GLP-1s Drive Explosive Insurer Drug Spending

December 8, 2025

AI Chest X-Rays Still Need Human Oversight

December 8, 2025

Gilead CAR-T Shows Strong Multiple Myeloma Data

December 7, 2025

Antipsychotic Use Surges Among Older Americans

December 4, 2025

Abbott CGM Malfunction Raises Safety, Regulatory Risks

December 4, 2025

Digital Health M&A Accelerates on AI Momentum

December 1, 2025

Insurers Cut Medicare Commissions to Deter Costs

November 26, 2025

Abbott Acquires Exact Sciences in $21B Bet

November 20, 2025

Judge Approves Purdue Opioid Settlement, Sacklers Pay

November 18, 2025

GLP-1 Weight Loss Drugs Reach Mass Adoption

November 14, 2025

FDA Reshapes Vaccine Regulation from the Inside

November 12, 2025

FDA Fast-Tracks Key Drugs with New Priority Vouchers

November 7, 2025

Recursion CEO Exits; Leadership Shifts Toward Commercialization Focus

November 5, 2025

Braveheart Bio Raises $185M for Heart Disease Drug

November 5, 2025

Telehealth Firms Bet on Unproven GLP-1 Microdosing Trend

November 4, 2025

Sarepta Falters as Duchenne Drug Trials Disappoint Investors

November 4, 2025

Novo, Pfizer Battle for $10B Obesity Biotech Metsera

November 4, 2025

uniQure Stock Plunges 50% After FDA Data Concerns

November 3, 2025

Kimberly-Clark Acquires Kenvue, Investors Skeptical of $48.7B Deal

November 3, 2025

Pfizer Sues Novo Nordisk, Intensifying Weight-Loss Drug Battle

November 3, 2025

AI Transforming Healthcare Efficiency, Innovation, and Investment Opportunities

September 2, 2025